Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Reviewing Evidence and Patient Outcomes of Cheilectomy for Hallux Rigidus: A Systematic Review and Meta-Analysis.
J Clin Med
November 2024
1st Orthopaedics and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Cheilectomy is a joint-sparing surgery for the treatment of moderate stages of Hallux Rigidus (HR). The purpose of this systematic review was to assess the clinical outcomes, range of motion (ROM), complications, and revision rates associated with cheilectomy. A literature search of the PubMed, Scopus, and Cochrane databases was performed.
View Article and Find Full Text PDFPrevalence of atypical femoral fractures, a clinical update: A comparative retrospective study 7 years later.
Injury
September 2024
Section of Orthopedics, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
Article Synopsis
- Atypical femoral fractures (AFFs) are rare but serious injuries linked to bisphosphonate use, and understanding their incidence and risk factors is crucial for treatment.
- A study reviewed radiographs of femoral fractures in patients over 60 to identify cases of AFFs, finding a 10% occurrence in their sample, an increase from a previous study's 5%.
- While bisphosphonates are effective for preventing osteoporotic fractures, prolonged use may lead to an increased risk of AFFs, especially at specific sites of the femur.
Fibro-adhesive Bursitis: A Novel Sonographic Finding in Adhesive Capsulitis Patients and a Proposal of Management.
Rheumatol Ther
December 2024
Department of Orthopedic and Traumatological Surgery, IRCCS Rizzoli Orthopedic Institute, University of Bologna, Bologna, Italy.
Article Synopsis
- Adhesive capsulitis, or "frozen shoulder," is a painful condition linked to recent COVID-19 impacts, and treatment focuses on easing pain and improving shoulder mobility.
- A study involving 36 patients examined treatment outcomes from either glenohumeral hydrodistension or a combination of hydrodistension and bursal injection over 6 months.
- Results revealed that the combined treatment led to significantly better improvements in shoulder motion and pain reduction compared to hydrodistension alone.
Efficacy of using autologous cells with graft substitutes for spinal fusion surgery: A systematic review and meta-analysis of clinical outcomes and imaging features.
JOR Spine
September 2024
Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli Bologna Italy.
Over the past several decades, there has been a notable increase in the total number of spinal fusion procedures worldwide. Advanced spinal fusion techniques, surgical approaches, and new alternatives in grafting materials and implants, as well as autologous cellular therapies, have been widely employed for treating spinal diseases. While the potential of cellular therapies to yield better clinical results is appealing, supportive data are needed to confirm this claim.
View Article and Find Full Text PDFLatin American consensus recommendations for the management and treatment of patients with treatment-resistant depression (TRD).
Span J Psychiatry Ment Health
September 2023
Research Center on Neurosciences, University of Palermo, Buenos Aires, Argentina; Department of Psychiatry, Queen's University, Kingston, Ontario, Canada. Electronic address:
Unlabelled: Despite the abundance of literature on treatment-resistant depression (TRD), there is no universally accepted definition of TRD, and available treatment pathways for the management of TRD vary across the Latin American region, highlighting the need for a uniform definition and treatment principles to optimize the management of TRD in Latin America.
Methods: Following a thematic literature review and pre-meeting survey, a Latin America expert panel comprising 14 psychiatrists with clinical experience in managing patients with TRD convened and utilized the RAND/UCLA appropriateness method to develop consensus-based recommendations on the appropriate definition of TRD and principles for its management.
Results: The expert panel agreed that 'treatment-resistant depression' (TRD) is defined as 'failure of two drug treatments of adequate doses, for 4-8 weeks duration with adequate adherence, during a major depressive episode'.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!